Jacobs Levy Equity Management, Inc Axogen, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 196,000 shares of AXGN stock, worth $3.13 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
196,000
Previous 203,901
3.87%
Holding current value
$3.13 Million
Previous $3.77 Million
43.64%
% of portfolio
0.01%
Previous 0.02%
Shares
22 transactions
Others Institutions Holding AXGN
# of Institutions
169Shares Held
40.4MCall Options Held
69.1KPut Options Held
0-
First Light Asset Management, LLC Edina, MN4.53MShares$72.4 Million7.55% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$52 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$43.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.51MShares$40.1 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.93MShares$30.9 Million0.03% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $676M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...